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Abstract: 
Chromosome 22q11 deletion syndrome (22q11DS) is associated with elevated rates of 
schizophrenia and other psychoses in adulthood. Childhood morphologic brain abnormalities are 
frequently reported, but the significance of these and their relationship to the development of 
schizophrenia are unclear. We sought to delineate midline neuroanatomical abnormalities in 
nonpsychotic children with 22q11DS and their age- and sex-matched controls and compare these 
to those reported in individuals with schizophrenia. On qualitative analysis, we found a high 
incidence of midline developmental abnormalities (cavum septum pellucidum, or CSP). On 
quantitative analysis, the total corpus callosum (CC) area was significantly increased in the 
patient group and among the subregions, the patients had a significantly larger isthmus. These 
findings of an increased area of the corpus callosum, specifically the isthmus, have not been 
reported before in individuals with 22q11DS. We also found a relative lack of the age-related 
increase in the size of the corpus callosum in the children with 22q11DS. There were no 
differences in cerebellar vermis measurements between the patient and control groups. Our 
findings are indicative of frequent midline brain anomalies, including dysgenesis of the corpus 
callosum, in nonpsychotic children with 22q11DS. Although the increased size of the corpus 
callosum in our 22q11DS patients is in direct contrast to the decrease seen in schizophrenia, the 
high frequency of structural midline abnormalities in these nonpsychotic children with 22q11DS 
is similar to that seen in schizophrenia. Further longitudinal studies on these children will help 
determine which of these structural abnormalities is/are pertinent to the development of 
psychosis. 
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Article: 
Introduction 
Chromosome 22q11 deletion syndrome (22q11DS) is a common genetic condition, with a 
prevalence of 1/2000 to 1/4000 [Shprintzen, 2000], [Tezenas du Montcel et al., 1996] and 
[Wilson et al., 1994]. Also known as DiGeorge or velocardiofacial syndrome, the deletion causes 
variable manifestations, mainly consisting of developmental delays and learning disabilities (80–
100%), mental retardation (50%), congenital heart disease (70%) and palatal problems (70%) 
[Gerdes et al., 2001], [Moss et al., 1999], [Shprintzen et al., 1981] and [Swillen et al., 1997]. The 
diagnosis is made by chromosome analysis and fluorescence in situ hybridization (FISH), 
demonstrating the deletion at band q11.2 on chromosome 22. Most deletions occur 
sporadically—in 10–15% of patients, an affected parent is found on FISH analysis. 
 
Recent retrospective studies have reported that children with 22q11DS have a markedly 
heightened risk (approximately 40%) of developing schizophrenia and mood psychoses in 
adulthood [Murphy et al., 1999], [Papolos et al., 1996], [Pulver et al., 1994] and [Shprintzen et 
al., 1992]. These preliminary findings provide the strongest known link between psychosis and 
an identified genetic abnormality. Conversely, about 1–6% of individuals with schizophrenia 
have been found to have a deletion of 22q11.2 [Karayiogou et al., 1995], [Murphy et al., 1998] 
and [Yan et al., 1998]. Thus, 22q11DS represents a specific genetic subtype of schizophrenia, 
but the pathophysiology remains poorly understood. 
 
In the last decade, qualitative MRI studies in children and adults with 22q11DS have shown 
structural brain abnormalities. In children, a small cerebellar vermis, white matter hyperdensities, 
cysts adjacent to the anterior horns, cerebellar and midline anomalies, and enlarged Sylvian 
fissures have been reported [Bingham et al., 1997], [Lynch et al., 1995], [Mitnick et al., 1994], 
[Papolos et al., 1996] and [Vataja and Elomaa, 1998]. 
 
With the application of quantitative (morphometric) MRI analyses, additional structural brain 
abnormalities have been described in nonpsychotic children with 22q11DS. These include 
reduced total brain volume, increased mid-corpus callosum area, white matter reductions in 
nonfrontal areas, gray matter reduction in the parietal lobe, relatively large frontal lobes, 
decreased right cerebellar tissue volume, small temporal lobe, superior temporal gyrus and 
hippocampus and increased basal ganglia volume [Eliez et al., 2000], [Eliez et al., 2001], [Eliez 
et al., 2002], [Kates et al., 2001] and [Usiskin et al., 1999]. 
 
In adults with 22q11DS who had developed schizophrenia, midline developmental abnormalities 
(45%), white matter hyperdensities (90%) and cerebellar atrophy (36%) were seen on a 
qualitative MRI analysis (Chow et al., 1999). On quantitative MRI studies, septum pellucidum 
abnormalities (40%), smaller cerebellum, gray matter deficits and large ventricles were reported 
[Chow et al., 2002] and [van Amelswoort et al., 2001]. Frontal lobe size was reduced in the 
second study, similar to the findings in schizophrenia in the general population (Lawrie and 
Abukmeil, 1998), but in contradiction to the studies in young nonpsychotic children with 
22q11DS discussed above. Thus, while several abnormalities have been described in 
nonpsychotic and psychotic individuals with 22q11DS, there are differences from one study to 
another and the relationship between these and the development of schizophrenia is unclear. 
 
The CC is a key midline white matter structure that carries fibers that connect cortical areas in a 
topographical manner. Changes in the CC provide a way of examining anatomical abnormalities 
in the corresponding cortical areas. Studies of the CC in schizophrenia have provided insights 
into various underlying neurodevelopmental abnormalities (reviewed by [Keshavan et al., 2002] 
and [Shenton et al., 2001]). 
 
We performed a cross-sectional study in nonpsychotic preadolescent and adolescent children 
with 22q11DS to characterize neuroanatomical abnormalities by qualitative and quantitative 
methods, and to compare and contrast these changes to those found in individuals with 
schizophrenia. We hypothesized that we would see a high frequency of midline structural 
developmental abnormalities such as cavum septum pellucidum and decreased size of the corpus 
callosum (CC) based on the reports of decreased intracranial volume in 22q11DS children and 
the frequent reports of decreased CC area in individuals with schizophrenia. Based on previous 
reports of relatively large frontal lobes in children with 22q11DS, we expected to find 
differences in size between the subregions of the CC. We also expected to see cerebellar 
hypoplasia, a common feature in 22q11DS and in schizophrenia. 
 
Materials and methods 
Subjects 
Thirteen children with 22q11DS between the ages of 7 and 18 years were recruited into the 
study. All had had confirmation of the diagnosis by FISH analysis. Thirteen control subjects 
were matched by age (within 9 months) and gender to the patients. The patients were recruited 
from the Medical Genetics Clinic at Wake Forest University School of Medicine (WFUSM) and 
the control subjects from Pediatric Clinics at WFUSM and from private practices outside the 
medical school. A three-generation pedigree was obtained by an experienced board-certified 
genetic counselor (MNB). The family history was assessed for the presence of mental illness, 
learning disabilities and other problems that may indicate other individuals affected with either 
22q11DS, or another developmental or genetic disorder. Control subjects who had either a 
family or personal history of a psychotic illness, or a history of mental retardation/developmental 
delay were excluded from the study. For children with 22q11DS, the occurrence of psychosis in 
other family members who are affected by 22q11DS was not considered as an exclusion 
criterion. However, the occurrence of psychosis in family members who did not have 22q11DS 
would result in exclusion from the study. A history of multiple congenital anomalies was also 
used as an exclusion criterion since those could be indicative of an underlying genetic disorder. 
 
Medical evaluation 
The medical information on patients and control subjects was carefully reviewed for medical and 
psychological problems. A detailed structured history, including prenatal and perinatal events 
that may have had a bearing on development, was obtained. None of the patients or control 
subjects had a psychotic illness at the time of the study. Control and patient subjects received a 
targeted examination to detect subtle dysmorphic features. 
 
One control subject and three patients were on stimulant medications for ADHD. Two other 
patients were on Valproate for a seizure disorder. 
 
MRI studies 
Imaging studies were performed at Wake Forest University School of Medicine, with a General 
Electric (GE) 1.5-T Signa System running 8.4 M4 software. A set of sagittal scout images (2D 
fast spin echo, TR = 2500 ms, echo time (TE) = 88 ms, FOV = 240 mm, approximately 10 slices, 
slice thickness = 5 mm, slice gap = 1.5 mm, NEX = 1, matrix = 256 × 128, scan time = 50 s) was 
collected to verify patient position, cooperation and image quality. The midsagittal slice was 
required to show full visualization of the cerebral aqueduct. A set of proton density and T2-
weighted axial images was then collected covering the whole brain (2D fast spin echo, TR = 
3000 ms, TE = 36 and 96 ms, echo train length (ETL) = 8, FOV = 26 × 26, approximately 110 
slices, slice thickness = 3 mm, slice gap = 0 mm, NEX = 1, matrix = 256 × 192). Three-
dimensional spoiled gradient echo imaging was performed in the axial plane (spoiled gradient 
recalled, SPGR sequence, TR = 25 ms, TE = 5ms, nutation angle = 40°, FOV = 180 mm in the 
phase encoding direction and 240 mm in the read direction, slice thickness = 1.5 mm, NEX = 1, 
matrix = 256 × 192, scan time = 10 min and 18 s) to obtain 124 images covering the entire brain. 
The MR images were examined qualitatively for clinical abnormalities by a pediatric neurologist 
(CCS). 
 
Morphometric evaluation 
Morphometric measurements were conducted by a single trained rater (SM) blinded to the study 
hypotheses, subject identification and clinical data, using software (NIH IMAGE; Version 1.62), 
which allows manual tracing with a cursor, stripping of noncerebral tissues and reliable 
segmentation of gray and white matter and CSF (Keshavan et al., 1995). There was no motion 
artifact on any of the scans measured. The midsagittal view was selected (best visualization of 
the CC, the septum pellucidum, the cerebellum and the aqueduct) and was confirmed in the 
orthogonal plane. The rater manually traced the outline of the CC. A line was drawn connecting 
the most anterior part of the genu to the most posterior part of the splenium (the A-P line). The 
CC was divided into the genu, the body, the isthmus and the splenium (Witelson, 1989). These 
areas of the CC were further divided to measure specific parts of the CC that we expected to find 
changes in our patient population (Fig. 1). 
 
 
Fig. 1. Diagrammatic representation of the scheme used to divide the CC into its subregions. 
The midpoint of the A-P line within the genu was connected to the midpoint of the line 
separating the genu from the body. This line was trisected by two perpendicular lines, thus 
dividing the genu into its anterior, middle and posterior parts. The splenium was divided by a 
line connecting the midpoint of the A-P line in the splenium to the midpoint of the line 
separating the isthmus and the splenium. Two perpendicular lines trisecting this line divided the 
splenium into anterior, middle and posterior regions (Fig. 1). Intracranial area was calculated by 
tracing along the inner table of the skull, along the basisphenoid and across the foramen 
magnum. The interrater reliabilities (interclass r) for these measurements were very high on 10 
scans measured by two raters (SM and SS) (r = 0.97–0.99). Intrarater reliabilities (intraclass r), 
based on the same rater (SM) measuring 10 scans twice about a month apart, were also high (r > 
0.96). 
 
Statistical analysis 
Multiple analysis of covariance was used to test for differences in the parts of the CC (the genu, 
body, isthmus and splenium), using intracranial area as a covariate, using an α level at P < 0.10. 
On multiple analysis of covariance (MANOVA) with intracranial area as a covariate, an F = 2.92 
and P < 0.04 were found. Where significant, individual analysis of covariance (ANOVA) was 
examined for the subregions of the CC. Correlations between age and the CC measurements 
were computed separately after partialling out the intracranial area. We also performed statistical 
analyses using head circumference as a covariate. Since some of our patients were on 
medications due to ADHD and seizures, we reran the analyses by using medication status as a 
covariate. 
 
Results 
Medical status 
The patients with 22q11DS had many medical problems, such as congenital heart disease, palatal 
problems (velopharyngeal insufficiency with or without a submucous cleft) and less frequently 
hypoparathyroidism and immune deficiency. All had experienced developmental delays and 
learning difficulties in school. Of t he 13 patients, five had a parent affected by 22q11DS. One of 
the affected parents has been diagnosed with paranoid schizophrenia. 
 
Of the control subjects, none had medical or developmental problems; two had attention deficit 
hyperactivity disorder (ADHD). Pertinent characteristics of the patient and control subjects are 
listed in Table 1. 
Table 1. 
 22q11DS patients (n = 13) Control subjects (n = 13) 
Agea 10.04 (4.05) 10.8 (4.2) 
Sex (M/F) 8/5 8/5 
CHDb 5/13 none 
 22q11DS patients (n = 13) Control subjects (n = 13) 
Palate abnormal 12/13 none 
ADHD/ODD 6/13 2/13 
ADHD/ODD = attention deficit hyperactivity disorder, oppositional defiant disorder. 
a The values for age indicate the mean (SD). 
b Congenital heart disease. 
 
Quantitative (morphometric) MRI analysis 
The total area of the CC was significantly increased in patients with 22q11DS compared to 
control subjects (F = 10.52, P = 0.004) (Table 3 and Fig. 2). When the regions of the CC were 
separately analyzed, the area of the isthmus of the CC in patients with 22q11DS was larger in the 
children with 22q11DS compared to the controls (F = 4.68, P = 0.04). There was a trend for the 
genu to be larger as well in the patient group (F = 3.64, P = 0.07). Measurements of the other 
subdivisions of the CC and the cerebellar vermis were not significantly different between the two 
groups. Correlations between age and the CC area after partialling out the intracranial area 
showed an absence of a positive correlation between the age and the size of the CC in the patient 
group (β = 0.05, P = 0.93) compared to the control group (β = 0.93, P = 0.03) (Fig. 3). ANOVA 
carried out with diagnosis as the grouping variable and head circumference as a covariate 
revealed a significant diagnosis effect on total CC area (df = 1,23; F = 7.25; P = 0.01) and on 
isthmus size (df = 1,23; F = 4.66; P = 0.04). Thus, the group differences for total CC area 
remained significant, indicating that intracranial volume (head circumference is an indirect 
measure of intracranial volume) was not a confounding factor. Lastly, the MANOVA and 
ANOVA were rerun, comparing the 22q11DS and control subjects, using medication status as a 
covariate. The MANOVA and ANOVA for the total CC area remained significant (P < 0.01) and 
the ANOVA for the isthmus was marginally significant (P < 0.10). 
 
Table 3. CC subregions (cm2) in 22q deletion subjects vs. healthy controls 
Area 22q11DS patients Control subjects F P 
Total CC 6.65 (1.69) 5.44 (1.22) 10.52 0.004 
Genu 2.49 (1.03) 1.99 (0.53) 3.63 0.07 
Area 22q11DS patients Control subjects F P 
Anterior body 0.86 (0.81) 0.55 (0.14) 1.74 0.20 
Posterior body 0.60 (0.16) 0.53 (0.13) 2.14 0.16 
Isthmus 0.62 (0.20) 0.49 (0.12) 4.68 0.04 
Splenium 1.78 (0.63) 1.68 (0.41) 0.20 0.66 
ICA 140.41 (26.41) 138.52 (22.86) 0.04 0.84 
 
Values are means (SD).MANOVA with ICA as a covariate Rao R(5,19) = 2.92; P < 0.04. 
Individual ANOVAs with ICA as covariate (df = 1,23) are presented in the table.Values are 
mean (SD).Measurements expressed as cm2.ICA = intracranial area. 
 
 
Fig. 2. Representation of the CC area in the 22q11DS patients compared to control subjects. 
 
 
Fig. 3. Graphic representation of the correlation of the CC area and age, in the patients and 
control subjects, after partialling out the intracranial area. 
 
Discussion 
On qualitative analysis, structural brain abnormalities were common in our patients with 
22q11DS compared to their age- and sex-matched control subjects. The most frequent 
abnormality was one of midline aberrancy (cavum septum pellucidum). A cavum septum 
pellucidum (CSP) is a common developmental abnormality, in which the leaflets of the septum 
pellucidum do not fuse in the midline, partially or completely (then known as cavum vergae) and 
is seen in about 1% of the general population [Nopoulos et al., 1997] and [Nopoulos et al., 1998]. 
A CSP has been reported to occur in up to 45% of individuals with schizophrenia (reviewed by 
Shenton et al., 2001). It has been reported with the same frequency in adults with 22q11DS who 
have schizophrenia (van Amelswoort et al., 2001). CSP has also been reported to occur with a 
higher frequency in early onset schizophrenia (Nopoulos et al., 1998) and is postulated to be 
related to early onset/severe illness in these cases, indicating brain dysgenesis, which is thought 
to be a major factor in the causation of schizophrenia. A CSP is thought to be reflective of 
developmental abnormalities of the structures bordering the septum pellucidum, such as the 
corpus callosum and the hippocampus (structures frequently reported to be abnormal in 
schizophrenia). The exact significance of the CSP in our patients is hard to determine in this 
cross-sectional study. To date, there are no longitudinal studies in children with 22q11DS that 
have examined the correlation between CSP and the occurrence of schizophrenia. However, 
since CSP is a marker of abnormal neurodevelopment (including the CC and the hippocampus), 
finding it frequently in a population at high risk for schizophrenia such as 22q11DS lends 
credence to the neurodevelopmental hypothesis of schizophrenia. Our hypothesis of finding 
cerebellar abnormalities as part of the brain dysgenesis was not substantiated on quantitative 
analysis, although on qualitative analysis, we found two individuals with hypoplasia of the 
cerebellar vermis. 
 
Our quantitative measurements of the CC and its regions children in with 22q11DS showed an 
increase in the total area of the CC and the isthmus compared to age- and sex-matched control 
subjects. These findings have never been reported before in nonpsychotic children with 22q11DS 
to the best of our knowledge. Increased size of the midbody of the CC has been described in 
children with 22q11DS who had schizophrenia, but in a small sample size of three patients 
(Usiskin et al., 1999). The finding of an increased area of the CC in our study sample is 
intriguing, since typically, abnormalities of the CC seen in other genetic conditions (e.g. 
Williams syndrome, Fragile X syndrome) as well as in nonspecific mental retardation consist of 
atrophy or hypoplasia/agenesis of the CC and not hypertrophy [Brunberg et al., 2002], [Schmitt 
et al., 2001], [Soto-Ares et al., 2003] and [Tomiaulo et al., 2002]. Since cognitive abnormalities 
are seen in these genetic conditions as well as 22q11DS, it seems likely that the unique finding of 
a larger CC in patients with 22q11DS is more likely to be related pathogenetically to psychosis 
which is also a distinctive feature of this condition. 
 
We also compared the CC findings in our study with CC changes reported in other common 
childhood conditions—attention deficit hyperactivity disorder (ADHD), Tourette syndrome and 
obsessive compulsive disorder (OCD). Several studies have documented a smaller total area of 
the CC and variably smaller subregions of the CC in children with ADHD [Bumgardner et al., 
1996], [Giedd et al., 1994], [Hill et al., 2003], [Hynd et al., 1991], [Lyoo et al., 1996], [Paule et 
al., 2000] and [Semrud-Clikeman et al., 1994]. In Tourette syndrome, studies have not been 
consistent—both an increase in CC area [Bumgardner et al., 1996] and [Moraiarty et al., 1997] 
and decreased CC area have been reported (Peterson et al., 1994). In the few quantitative brain 
MRI studies done on OCD in children, the findings range from hypoplasia of the CC (Farchione 
et al., 2002), no significant findings [Jenike et al., 1996] and [Kellner et al., 1991] to an increase 
in total CC area and subregions except the isthmus (Rosenberg et al., 1997). Our findings of an 
increased area of the CC is in direct contrast to that described in ADHD and thus cannot be 
ascribed to the occurrence of ADHD in our patients. In addition, analyses performed using 
medication status as a covariate showed that medication status (for ADHD and seizures) did not 
account for the differences between the 22q11DS and control groups. None of our patients had 
Tourette syndrome or OCD that could have been a confounding factor. 
 
The CC connects the two cerebral hemispheres and continues to develop throughout childhood 
into adulthood, unlike other areas of the brain (Pujol et al., 1993). The subregions (genu, body, 
isthmus and the splenium) carry interhemispheric fibers from the heteromodal and unimodal 
regions of the cortex. Thus, changes within specific areas of the CC may indicate underlying 
abnormalities of the corresponding cortical areas. The increased size of the isthmus, which 
carries fibers that have heteromodal functions from the inferior parietal cortex, may be reflective 
of increased axonal size/number of the fibers originating from this area. Interestingly, the parietal 
cortex has been thought to be related to the visual–spatial and phonological processing deficits in 
children with 22q11DS [Kates et al., 2000] and [Kates et al., 2001]. However, the findings in that 
quantitative study of MRI in children with 22q11DS showed white matter reductions in the 
parietal areas, in contrast to the study by Eliez et al. (2000) which showed reductions in the gray 
matter of the parietal lobe. Both of these studies did not have data on the measurement of the CC. 
We suggest that the increased size of the isthmus of the CC may be due to increased size or 
number of axons from the inferior parietal cortex. There was a trend for increased size of the 
genu in our patient group. Since the genu connects the frontal cortices, this may suggest an 
increased size or number of axons from this area. Corroborating this is the finding of relatively 
large frontal lobes in two previous quantitative MRI studies [Eliez et al., 2000] and [Kates et al., 
2001]. 
 
The finding of a dampening of the age-related increase in the size of the CC in our patient group 
compared to our control group has not been reported before in 22q11DS. Normally, the area of 
the subregions of the CC increases with age during childhood and early adulthood up to the early 
20s, except for the isthmus (Keshavan et al., 2002). This increase in size is thought to be related 
to an increase in axonal size or due to continued myelination, long after other areas of the brain 
have matured. Myelinated axons propagate neural signals in a fast manner that is critical for 
normal cognition and motor development. Our finding of a lack of this age-related increase in the 
CC size in 22q11DS children may be due to the lack of increased myelination that would 
normally be expected to occur through childhood. Interestingly, this finding is similar to the CC 
changes in children with OCD (Rosenberg et al., 1997). However, none of our patients had OCD 
at the time of MRI imaging and thus it is unlikely that this change is due to concurrent OCD. 
Rather, it may be indicative of underlying abnormal neurodevelopment in both children with 
22q1DS and those with OCD. 
 
Although our findings of an increased size of the CC in 22q11DS children and lack of the age-
expected increase in the size of the CC in the same patient group may seem contradictory, they 
can be explained by the hypothesis that an initial increased size of the CC (due to either 
increased size or number of axons) is followed by an age-related relative failure of myelination 
of these axons, resulting in the absence of an age-related increase in the size of the CC. 
 
We compared our CC findings to those seen in schizophrenia in the general population and 
schizophrenia associated with 22q11DS. CC abnormalities are well described in individuals with 
schizophrenia ( [Keller et al., 2003] and [Keshavan et al., 2002]; reviewed by [Shenton et al., 
2001] and [Woodruff et al., 1995]) with most studies reporting a decrease in the size of the CC, 
specifically the anterior genu, anterior body, isthmus and anterior splenium, consistent with the 
reductions of the structures that are connected by these regions of the CC—the prefrontal, 
temporal and inferior parietal cortices (Schlaepfer et al., 1994). There is a paucity of quantitative 
data on CC structure in 22q11DS individuals who have already developed psychosis, with the 
two studies published thus far lacking precise measurements of the CC and its subregions [Chow 
et al., 2002] and [van Amelswoort et al., 2001]. Our finding of a lack of the expected positive 
correlation between age and CC area is similar to that reported in adolescents and young adult 
individuals with schizophrenia not associated with 22q11DS (Keshavan et al., 2002). This 
finding was indicative of a neurodevelopmental abnormality in these patients that persists into 
adulthood. Our similar findings provide further evidence of abnormal neurodevelopment in 
individuals at high risk of schizophrenia. 
 
The strengths of our study are that: (A) we used a group of nonpsychotic children at high risk for 
schizophrenia-like psychotic disorders and thus the data obtained are indicative of abnormal 
neurodevelopment preceding the onset of illness; (B) this is the only report that we are aware of 
that has evaluated the CC and its subregions by morphometric analysis, in children with 
22q11DS; (C) we also have qualitative MRI data that corroborate the abnormal midline 
development. The weaknesses are that our sample size is small and the data may be not be 
significant if IQ differences between the patient and control groups were corrected for. However, 
it is to be noted since low IQ is common in 22q11DS, controlling for IQ may remove the precise 
findings that are of interest and other investigators have stressed this point (Chow et al., 2002). 
We also did not measure regions of the brain that have been the focus of other studies, such as 
gray and white matter volumes and the frontal, temporal and parietal lobes. However, our CC 
findings provide indirect evidence of abnormalities in the inferior parietal cortex and abnormal 
CC maturation with age in children with 22q11DS. The high frequency of CSP suggests 
underlying abnormal neurodevelopment of the hippocampus and the CC. Future studies that 
would specifically measure these areas of the brain should provide further information. 
 
In conclusion, our study demonstrated differences in midline development and CC morphology 
in nonpsychotic children with 22q11DS relative to normal controls. The finding of a larger size 
of the CC is a unique finding in this study. Further imaging studies in a longitudinal fashion in 
these children will help clarify the relationship of these structural abnormalities and the 
occurrence of schizophrenia. 
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